OceansBio co.,ltd. (XKON:332190)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,090.00
0.00 (0.00%)
At close: Aug 21, 2025

OceansBio co.,ltd. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
125.6516.89
Revenue Growth (YoY)
643.92%-
Cost of Revenue
36.54-
Gross Profit
89.1116.89
Selling, General & Admin
1,047706.38
Research & Development
785.72204.67
Other Operating Expenses
22.4810.42
Operating Expenses
1,9511,019
Operating Income
-1,862-1,002
Interest Expense
-50.36-26.66
Interest & Investment Income
0.860.3
Currency Exchange Gain (Loss)
-0.08-0.25
Other Non Operating Income (Expenses)
898.27474.83
Pretax Income
-1,013-554.1
Net Income
-1,013-554.1
Net Income to Common
-1,013-554.1
Shares Outstanding (Basic)
11
Shares Outstanding (Diluted)
11
Shares Change (YoY)
-0.01%-
EPS (Basic)
-686.00-375.00
EPS (Diluted)
-686.00-375.00
Free Cash Flow
-829.39-613.46
Free Cash Flow Per Share
-561.38-415.17
Gross Margin
70.92%100.00%
Operating Margin
-1482.09%-5934.56%
Profit Margin
-806.63%-3280.74%
Free Cash Flow Margin
-660.10%-3632.14%
EBITDA
-1,766-903.8
D&A For EBITDA
96.3798.52
EBIT
-1,862-1,002
Advertising Expenses
5.52-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.